Howard Hochster, MD, explains the outcomes of the ECOG-7208 study in 2nd line metastatic colorectal cancer (mCRC) patients at Annual Meeting 2018.
The outcomes of ECOG-7208 in 2nd line mCRC
Howard Hochster, MD, explains the outcomes of the ECOG-7208 study in 2nd line metastatic colorectal cancer (mCRC) patients at Annual Meeting 2018.